Health Care/Hospital

China Biologic Products to Present at the Rodman & Renshaw Annual China Investment Conference

TAI'AN, China, March 3 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic," or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that the Company's management team will present at the Rodman & Renshaw Annual C...

2010-03-03 21:00 676

China Baicaotang to Attend Rodman & Renshaw Annual China Investment Conference

LIUZHOU CITY, China, March 3 /PRNewswire-Asia/ -- China Baicaotang Medicine Limited, (OTC Bulletin Board: CNBI), ("China Baicaotang" or the "Company"), the leading pharmaceutical distributor, retail pharmacy, and manufacturer of pharmaceuticals and medical-related products in Guangxi Province, C...

2010-03-03 21:00 673

China Nepstar Chain Drugstore Announces Annual Dividend

SHENZHEN, China, March 3 /PRNewswire-Asia/ -- China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("China Nepstar" or the "Company"), the largest drugstore chain in China based on the number of directly operated stores, today announced that the Board of Directors has declared a cash dividend of US$0....

2010-03-03 16:30 756

China Medical Technologies Reports Third Fiscal Quarter Financial Results

BEIJING, March 3 /PRNewswire-Asia/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced its unaudited financial results for the third fiscal quarter ended December 31, 2009 ("3Q FY2009"). The Compa...

2010-03-03 16:00 655

Asia Pharm R&D 2010 - New CRO Trends Become Focus of Industry

SHANGHAI, March 3 /PRNewswire-Asia/ -- Shanghai will welcome Asia Pharm R&D 2010 on March 4-5. This summit will converge local pharmaceutical companies, hospitals, global biotech companies and research institutes and labs in Asia, as well as those from further a field, as well as venture capital...

2010-03-02 22:00 618

Lotus Pharmaceuticals Announces New Prescription Drugs

BEIJING, March 3 /PRNewswire-Asia/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a growing developer and producer of prescription drugs and licensed national seller of pharmaceutical products in the People's Republic of China ("PRC"), today reported th...

2010-03-03 00:59 604

SinoHub Retains Hayden Communications as Corporate Communications Advisor

SANTA CLARA, Calif. and SHENZHEN, China, March 2 /PRNewswire-Asia/ -- SinoHub, Inc. (NYSE Amex: SIHI) today announced that it has retained HC International, Inc. as its strategic investor relations advisor to assist the Company in broadening its presence in the financial markets while helping in...

2010-03-02 22:00 655

Yongye International to Present at Rodman & Renshaw Annual China Investment Conference

BEIJING, March 2 /PRNewswire-Asia-FirstCall/ -- Yongye International, Inc. (Nasdaq: YONG), ("Yongye" or the "Company") a leading developer, manufacturer, and distributor of Shengmingsu brand plant and animal nutrient products in the People's Republic of China (PRC), today announced that the Co...

2010-03-02 21:00 738

Nutrastar International, Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing

HARBIN, China, March 2 /PRNewswire-Asia/ -- Nutrastar International Inc. (OTC Bulletin Board: NUIN; "Nutrastar" or the "Company"), a leading nutraceutical company which produces and distributes Chinese Golden Grass ("Cordyceps Militaris"), organic and specialty food products in China, today anno...

2010-03-02 20:00 706

Concord Medical to Report Fourth Quarter and Fiscal Year 2009 Unaudited Financial Results on Thursday, March 18, 2010

BEIJING, March 2 /PRNewswire-Asia/ -- Concord Medical Services Holdings Limited ("Concord Medical") (NYSE: CCM), operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that it will report its unaudited financial results for the fourth quarter and...

2010-03-02 18:00 669

WuXi PharmaTech Enters into Collaboration with J&JPRD, a division of Janssen Pharmaceutica for Preclinical Services and Training

SHANGHAI, March 2 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced it has reached an agreement with Johnson & Joh...

2010-03-02 00:00 760

Mindray Announces 2009 Fourth Quarter and Full Year Results

SHENZHEN, China, March 2 /PRNewswire-Asia/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the fourth quarter and full year ended December 31, 2009. ...

2010-03-02 05:45 541

China-Biotics, Inc. Inaugurated the Commercial Production of its New Production Facility

SHANGHAI, March 2 /PRNewswire-Asia/ -- China-Biotics, Inc. ("China-Biotics," the "Company") (Nasdaq: CHBT), the leading developer, manufacturer and distributor of probiotics products in China, today announced that its new bulk additive production facility has commenced commercial production ...

2010-03-02 05:06 557

China-Biotics, Inc. Appointed Grayling as Strategic Investor Relations Advisor

SHANGHAI, March 2 /PRNewswire-Asia/ -- China-Biotics, Inc. ("China-Biotics," "the Company") (Nasdaq: CHBT), the leading developer, manufacturer and distributor of probiotics products in China, today announced that that it has appointed Grayling to develop and implement a comprehensive communic...

2010-03-02 05:05 563

Shanghai ChemPartner's Animal Facility Awarded AAALAC Accreditation

SHANGHAI, March 1 /PRNewswire-Asia/ -- Shanghai ChemPartner, a leading China-based contract research organization and a wholly-owned subsidiary of ShangPharma, today announced that its animal facility has received accreditation from the Association for the Assessment and Accreditation of Lab...

2010-03-01 23:00 792

China Cord Blood Corporation to Announce Third Quarter Fiscal 2010 Earnings Results

Earnings Call Scheduled for March 5, 2010 HONG KONG, March 1 /PRNewswire-Asia-FirstCall/ -- China Cord Blood Corporation (NYSE: CO; "the Company") today announced its plan to release financial results for the third quarter of fiscal year 2010 on Friday, March 5, 2010, before the market open...

2010-03-01 21:30 881

China Pharma Holdings, Inc. Announces March Conference Participation

HAIKOU CITY, China, March 1 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE Amex: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that it will participate in the following conferences: -- Rodm...

2010-03-01 21:30 643

Lotus Pharmaceuticals to Commence Sarbanes-Oxley Compliance Project

BEIJING, March 1 /PRNewswire-Asia/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a growing developer and producer of prescription drugs and licensed national seller of pharmaceutical products in the People's Republic of China ("PRC"), today reported that t...

2010-03-01 21:00 532

China Biologic Products Retains O'Melveny & Myers LLP to Advise on Special Investigation

TAI'AN, China, March 1 /PRNewswire-Asia/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic," or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that the special committee of independent directors appointed by the Company's board of Direct...

2010-03-01 21:00 839

Co-Founder of VSEL(TM) Technology Joins NeoStem's Scientific Advisory Board

NEW YORK, March 1 /PRNewswire-Asia/ -- NeoStem, Inc. (NYSE: NBS) ("NeoStem" or the "Company"), an international biopharmaceutical company with operations in the United States and China, announced today that it has appointed to its Scientific Advisory Board ("SAB") Mariusz Ratajczak, M.D., Ph.D.,...

2010-03-01 21:00 643
1 ... 755756757758759760761 ... 869